In this episode, Dr. Paul Wheatley-Price sits down with Dr Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center in Hamilton, ON and Chair of LCC's Medical Advisory Committee. Dr. Juergens is one of the winners of the Quality Improvement Grant aimed at elevating the care and outcomes of Canadians living with metastatic NSCLC. She cha…

In this episode, Dr. Paul Wheatley-Price sits down with Nina Snyder, Chief Operations Officer at Alberta Lung. Nina introduces Alberta Lung as an organization and what they do to support Albertans living with lung disease, factors like radon and air quality that may lead to a lung cancer diagnosis, challenges like isolation, youth vaping and e-ciga…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Amir Safavi, final-year Radiation Oncology Resident at the University of Toronto, and Dr. Jillian Tsai, Staff Radiation Oncologist at Princess Margaret Cancer Centre. They preface the chat with radiation 101, describe what "oligo-" means in the context of oligoradiation, oligometastises & …

In this episode, Dr. Paul Wheatley-Price speaks to the team of The Palliative Care Early and Systematic (PaCES) Project out of the University of Calgary: Dr. Jessica Simon, Associate Professor and Head of the Division of Palliative Medicine; Lisa Shirt, RN, Clinical Nurse Specialist; and Tim Monds, stage 4 lung cancer survivor. What is the PaCES pr…

In the second episode of our "Research in Canada" series, Dr. Paul Wheatley-Price meets with Dr. Enam Alsrayheen, Health Outcomes Scientist at Cape Breton Regional Hospital, who is a recipient of the 2023 Geoffrey Ogram Memorial Research Grant. Dr. Alsrayheen speaks about her research implementing a community lung clinic in the rural areas of Cape …

In the first episode of our "Research in Canada" series, Dr. Paul Wheatley-Price speaks with Dr. Alison Wallace, Thoracic Surgeon and Associate Professor, Dalhousie University, recipient of a 2023 Lung Ambition Award. Dr. Wallace speaks about her research project focused on improving female patients’ quality of life when undergoing lung cancer surg…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Vishal Navani, Medical Oncologist at the Tom Baker Cancer Centre, and Dr. Andrea Fung, Thoracic Medical Oncologist in Kingston Health Sciences Centre. They chat about the latest developments in lung cancer research at the 2023 ESMO conference in Madrid, Spain this past October.…

Our fourth installment of the “Expanding Horizons" series is part one of a two-part discussion on creating screening opportunities. In part one, discover how lung screening can draw from the success of mammography in promoting early detection and improving outcomes for lung cancer patients. Meet our conversation leaders: Kim Sandler, MD, is an Asso…

As we advance in our "Expanding Horizons" series, come and join us as we explore the core components that underpin early detection, specifically focusing on referring providers and their critical role in this process. Meet our conversation leaders: Denise Lee, a volunteer spokesperson for the American Lung Association (ALA) and a lung cancer surviv…

In this special episode from our 2023 Evening of Hope, Dr. Paul Wheatley-Price sits down with Dann Wonser, lung cancer survivor and advocate in Portland, OR. Dann dives into his journey with lung cancer and beating the odds of survival once handed to him, sharing his inspiring journey with others, and his most recent venture in writing his book, Se…

Welcome back to our Lung Cancer 201: Expanding Horizons series. In this episode, we delve into the critical role of lung cancer navigators—the glue that holds together any comprehensive lung cancer program. So, what is the role of a navigator in a lung cancer setting? Join us while we sit down with four incredible and experienced navigators who are…

In this second installment of the two-part "Best of WCLC 2023" series, Dr. Paul Wheatley-Price continues the conversation with Dr. Cheryl Ho, Medical Oncologist at BC Cancer, and Dr. Jonathan Riess, Professor of Medicine at UC Davis in California, to discuss the highlights of this year's World Conference in Lung Cancer in Singapore. This episode fo…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Cheryl Ho, Medical Oncologist at BC Cancer, and Dr. Jonathan Riess, Professor of Medicine at UC Davis in California, to discuss the highlights of this year's World Conference in Lung Cancer in Singapore. A new wave of drugs for lung cancer, unique screening projects from around the globe, …

In this eye-opening episode, Dr. Paul Wheatley-Price sits down with Dr. Sara Moore, Medical Oncologist at The Ottawa Hospital, on the topic of Medical Assistance in Dying (MAID). What is MAID, the history behind it, how MAID works, and alternatives to MAID. ***Lung Cancer Canada acknowledges this may be a sensitive and emotional topic for some list…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Natasha Leighl, Medical Oncologist and Lung Site Lead at Princess Margaret Cancer Center on the highly requested topic of Treatment Upon Progression: What's Next. Where and why do cancers become drug-resistant, what can we do about it, the challenges of the regulatory process for new treat…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Shantanu Banerji, Associate Professor at UManitoba and Medical Oncologist at CancerCare Manitoba, and Dr. Parneet Cheema, Director of Cancer Care and Medical Oncologist at William Osler Health System, about all the new developments at ASCO this year.…

In this episode, Dr. Paul Wheatley-Price sits down with Filomena Servidio-Italiano, Founder, President & CEO of the Colorectal Cancer Resource and Action Network (CCRAN) about her Uncle Sergio Servidio's journey with lung cancer, and her role as a caregiver.To read Uncle Sergio's story, visit http://bit.ly/SergioServidio…

In this episode, Dr. Paul Wheatley-Price chats with Dr. David Gandara, Thoracic Oncologist and Professor Emeritus at UC Davis, Sacramento, CA about all things immunotherapy. What is immunotherapy, how does it work, should early-stage patients consider immunotherapy, and why doesn't it work on patients with specific driver mutations?Listen to our pr…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Dan Breadner, Assistant Professor in Medical Oncology at the University of Western Ontario, about everything you need to know about EGFR-Positive Lung Cancer. What is EGFR, how do you test for it, and what's the latest in EGFR lung cancer research? All these questions answered in our lates…

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Cheryl Ho, Clinical Associate Professor at UBC and Medical Oncologist at BC Cancer Agency, about all things clinical trials. What is a clinical trial and why are they important? Why is there eligibility criteria and what happens if I don't meet them? Are they really safe? All these questio…

In this episode, Dr. Paul Wheatley-Price sits down with Andrea Redway, a stage 4 lung cancer patient in Ottawa, ON about her inspiring cancer journey and how she grew into being the incredible advocate about the disease that she is today.By Lung Cancer Canada

Welcome to "Lung Cancer 201: Expanding Horizons," our new series focusing on the challenges unique to established programs, clinicians, researchers, and advocates. You've made it past the first hurdle; time to explore what's next. In this first episode, Dr. Ella Kazerooni sits down with Dr. Robert Smith and Dr. Gerard Silvestri to discuss advances …

In this episode, Dr. Paul Wheatley-Price sits down with Dr. David Dawe, Medical Oncologist at Cancer Care Manitoba, and Dr. Stephanie Snow, President of LCC and Medical Oncologist at QEII Health Sciences Center to discuss their experiences and highlights at the ESMO Congress this past September in Paris, France.…

Dans notre premier podcast en français, l'oncologue médical Dr. Normand Blais parle avec Catherine Larose, survivante d'un cancer du poumon de stade 4 et défenseure passionnée des patients, au cours de son parcours.* * *In our first French podcast, medical oncologist Dr. Normand Blais speaks with Catherine Larose, stage 4 lung cancer survivor and p…

In part 2 of this series, Dr. Paul Wheatley-Price speaks to lung cancer survivor and tireless advocate, Angus Pratt on his involvement on an advisory council for research with the Canadian Cancer Society, and recent experience attending medical conferences as a patient. Visit Angus' blog at https://journey.anguspratt.ca/…

In this episode, Dr. Paul Wheatley-Price speaks to lung cancer survivor and tireless advocate, Angus Pratt. Angus details his cancer journey and how his diagnosis worked his way into becoming an advocate in the lung cancer space. Visit Angus' blog at https://journey.anguspratt.ca/By Lung Cancer Canada

In this episode, Dr. Paul Wheatley-Price speaks to Dr. Nicole Culos-Reed, professor at the University of Calgary and lung cancer patient Duane Kelly on the importance of exercise for lung cancer patients, its numerous health benefits, and the national EXercise for Cancer to Enhance Living well (EXCEL) program. Duane shares his lung cancer journey a…

In this episode, Dr. Paul Wheatley-Price speaks to Dr. Andrea Fung of the Kingston Health Sciences Center, and Dr. Shaqil Kassam of the Southlake Regional Health Centre on the key takeaways and highlights at the ASCO 2022 Annual Meeting in Chigago earlier in June.By Lung Cancer Canada

In this episode, Dr. Paul Wheatley-Price speaks to lung cancer survivor Stephen Sollows about his life, faith, cancer journey and the story of the current #HopeArmy t-shirt design. To purchase your own tee, visit https://www.hopearmy.ca/.By Lung Cancer Canada

In this episode, Dr. Paul Wheatley-Price speaks to Dr. David J. Stewart of the Ottawa Hospital about his new book "A Short Primer on Why Cancer Still Sucks", which addresses common, vexing questions about cancer and what future changes we can anticipate. You can purchase the book online at Chapters/Indigo, Barnes and Noble, or Amazon. To read the p…

Part 4 of the series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

Part 3 of the series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

Part 2 in this series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

In the first of a series, Dr. Paul Wheatley-Price speaks with Dr. Garth Nicholas, of The Ottawa Hospital about clinical trials that changed how lung cancer is treated. Based on Dr. Nicholas' fascinating and informative tweets for Lung Cancer Awareness Month in November 2021. You can find Dr. Nicholas on twitter @GarthNicholas1.…

To wrap up our “Power of Partnerships” series, Dr. Douglas Wood has a conversation about the thoracic surgeon’s role in lung cancer with fellow thoracic surgeons Dr. Leah Backhus, Dr. Tom Varghese, and Dr. Farhood Farjah. They discuss the surgeon’s role in screening programs, evaluating nodules from a surgical perspective, and how to avoid harm and…

Continuing the focus on patients, Dr. Efrén J. Flores speaks with Dr. Chi-Fu Jeffrey Yang, Alexandra L. Potter, and Angela Zhou from the American Lung Cancer Screening Initiative about outreach to populations vulnerable to lung cancer that are underserved in lung screening. This includes identifying how stigma is a barrier, finding ways to establis…

Continuing our special series, What's New In: Dr. Wheatley Price discusses new advances in Radiotherapy with Dr. Corinne Faivre-Finn of the NHS Foundation Trust and Dr. David Palma of the London Health Sciences Centre. This webinar aired on December 1, 2021,By Lung Cancer Canada

In this special episode that aired as a webinar in our What's New In: series, Dr. Paul Wheatley-Price discusses the newest and upcoming treatments for rare cancer subtypes like RET, MET, HER2 and more with Dr. Alexander Drilon of the Memorial Sloan Kettering Cancer Center, and Dr. Parneet Cheema of the William Osler Health System…

For 2022's National Patient Recognition Week, Elridge Proctor of the Go2 Foundation sits down with Heidi and Pierre Onda of the White Ribbon Project and Nichelle Stigger from LUNGevity to discuss how they went from patient to patient advocates and ways those without lung cancer can use their voices for change. Elridge Proctor, MPA, is the Senior Di…

Dr. Debra Dyer and experienced patient advocates Rhonda Meckstroth and Gina Hollenbeck discuss shifting lung cancer from a quantitative perspective to a patient and family centered one, including changing the face of lung cancer, and how medicine can further support patients beginning immediately post diagnosis. Debra Dyer, MD, FACR, is the Chair o…

In this episode, Dr. Wheatley-Price speaks to lung cancer survivor, Terry Morey and his wife, Joyce Morey about Terry's cancer journey and the invaluable role of a caregiver.By Lung Cancer Canada

Dr. Nichole Tanner, nurse practitioner Shannon Magee, and experienced patient advocate Jim Pantelas discuss the unique challenges of treating lung cancer through the Veterans Administration (VA) hospital system, and the support provided to veterans pre- and post-diagnosis. Nichole Tripician Tanner, MD, MSCR, is a pulmonologist at the Ralph H. Johns…

Dr. Ruth Carlos, Dr. Lucy Spalluto, and patient advocate Andrea Borondy-Kitts discuss social determinants of health and how they affect lung cancer diagnosis and treatment, including what disparities currently exist, how policy changes could reduce those disparities, and how to move closer to health equity. Ruth C. Carlos, MD, MS, FACR is a Profess…

In this episode, Dr. Paul Wheatley-Price speaks to Dr. Doreen Ezeife, Tom Baker Cancer Centre, Calgary, and Dr. Rosalyn Juergens, Juravinski Cancer Centre, Hamilton, about the highlights of lung cancer research in 2021.By Lung Cancer Canada

Dr. Jamie Studts continues the conversation about stigma and nihilism from the clinician scientist perspective with Dr. Jamie S. Ostroff and Dr. Lisa Carter-Harris, including how language contributes to stigma and the new International Association for the Study of Lung Cancer (IASLC) language guide. Jamie L. Studts, PhD, FSBM, is a Professor of Med…

Lung Cancer Voices - Jill Hamer Wilson by Lung Cancer CanadaBy Lung Cancer Canada

"The Power of Partnerships” limited podcast series will feature conversations currently happening in the world of lung cancer with the people pushing the field into the future. Dr. Jamie Studts and patient advocates Jill Feldman and Jim Pantelas discuss stigma surrounding lung cancer from internal and external sources and the work being done to com…

*This episode was originally part of the ACR Bulletin podcast and was recorded in Fall 2020. For the most up to date COVID-19 guidelines, please contact your local screening center. Dr. Debra Dyer, MD, finishes her conversation with Dr. Patricia Rivera, MD, with a discussion on the impact of the COVID-19 pandemic on lung cancer screening. As part o…

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. For part four of their discussion, Dr. Debra Dyer, MD, and Dr. Patricia Rivera, MD, discuss the importance of biomarker testing for patients with advanced NSCLC. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer…

*This episode was originally part of the ACR Bulletin podcast and recorded in 2020. For the most up to date information on USPSTF coverage, please visit the ACR website for the list of private payer that have adopted the criteria. In part three of this series, Dr. Debra Dyer, MD, and Dr. Patricia Rivera, MD, discuss the proposed USPSTF lung cancer …